Latest News

Timber Pharmaceuticals Announces Positive End-of-Phase 2 Meeting with FDA for TMB-001 in Moderate to Severe Congenital Ichthyosis

– Full data from Phase 2b CONTROL study presented at 2022 Winter Clinical Dermatology Conference – – Company plans to initiate Phase 3 study in ...

Nearly all people in the U.S. are within an hour of life-saving stroke care

Research Highlights: Researchers estimate that 91% of the U.S. population can reach an acute stroke ready hospital, primary stroke center or comprehensive stroke center ...

Death due to cardiovascular disease more likely among Black adults born in the U.S.

Research Highlights: A new study found Black adults born in the U.S. had a higher risk of death from cardiovascular disease and other causes ...

Young marijuana smokers may be at greater risk of recurrent stroke

Research Highlights: Among hospitalized adults, ages 18-44 who had a history of stroke or transient ischemic attack (TIA), the cause of another hospitalization was ...